MoneyWorks4Me

Sanjivani Paranteral informs about disclosures

20 Aug 2021 Evaluate

Sanjivani Paranteral has informed that the Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashwani Khemka.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..